AbC-19™ Rapid Test
The AbC-19™ Rapid Test is a single use rapid test for the detection of IgG antibodies in response to the SARS-CoV-2 virus or following vaccination.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great results
Diagnostics
It's quite simple and more effective than any other rapid test. However, it is also time consuming.
Review Date: 22 May 2022 | Abingdon Health
The AbC-19™ Rapid Test is able to confirm that IgG antibodies to the full Spike protein have been produced after vaccination or following direct exposure to the SARS-CoV-2 virus.
The AbC-19™ Rapid Test can be deployed across multiple populations and has the potential to inform vaccination programmes and health policy. The test can do this by showing how COVID-19 infection spreads through communities, where any why immunity to COVID-19 might be developing and how mass-immunisation campaigns could be designed.
The AbC-19™ Rapid Test is delivered at point of care (POC) using a blood sample from a finger-stick puncture, with test results ready in just 20 minutes.
Why use the AbC-19™ Rapid Test?
Confirms the presence of SARS-CoV-2 IgG neutralising antibodies in a small blood sample
Sensitivity: 98.03%, Specificity: 99.56%*
Minimal operator training required
CE marked for use by healthcare professionals
For use in multiple testing locations such as workplaces, pharmacies or doctors’ surgeries
COVID-19 antibody testing: Supporting and shaping future vaccine programmes and health policies
In this whitepaper from Abingdon Health, discover how rapid point of care semi-quantitative antibody testing can assist in the management of SARS-CoV-2.
The companion test to SARS-CoV-2 vaccination
Rivalling laboratory-based assays for sensitivity and specificity, AbC-19™ provides a quick and accurate route towards immunisation.
This whitepaper, from Abingdon Health, provides data on the performance of the AbC-19™ antibody test in a trial of individuals who had been vaccinated with the Pfizer-BioNTech vaccine.
The roles of antibody testing and vaccines
View the infographic to better understand the role antibodies have to play in combating the SARS-CoV-2 virus and how antibody rapid tests can be deployed across populations to inform vaccination programs.
Complete lateral flow outsourcing solutions
Find out more about Abingdon Health’s complete lateral flow outsourcing solutions, including;
- Full service solution
- Lateral Flow Development
- Nucleic Acid Lateral Flow Customisation
- Lateral Flow Manufacturing
- Reader Customisation
Charting the course to a post-COVID world
Download this whitepaper to learn how antibody testing will play a valuable role in overcoming COVID-19 and find out about Abingdon Health’s neutralizing antibody test, AbC-19™.
Key learnings include:
- How the body responds to SARS-COV-2
- The different approaches to antibody testing
- The UK-RTC Abc-19 Rapid Test
- The link between antibodies and immunity
- The route towards therapies and immunization
